<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00401284</url>
  </required_header>
  <id_info>
    <org_study_id>2005</org_study_id>
    <nct_id>NCT00401284</nct_id>
  </id_info>
  <brief_title>Efficacy Study of EVT 201 in the Treatment of Elderly Patients With Daytime Sleepiness</brief_title>
  <official_title>A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Hypnotic Efficacy of EVT 201 in Elderly Patient With Daytime Sleepiness</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Evotec Neurosciences GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Evotec Neurosciences GmbH</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether a compound known as EVT 201 is effective in
      treating elderly patients diagnosed with primary insomnia who also have moderate daytime
      sleepiness.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2006</start_date>
  <completion_date type="Actual">July 2007</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Polysomnography derived Total Sleep Time averaged over nights 1, 6 and 7</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean Multiple Sleep Latency Test at Day 8</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Psychomotor Vigilance Task at Day 8</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Karolinska Sleepiness Scale at Day 8</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Rey Auditory Verbal Learning Test at Day 8</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Profile of Mood State at Day 8</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Polysomnography derived variables averaged over nights 1, 6 and 7</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient reported evaluations of sleep quality and quantity over nights 1 to 7</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Benzodiazepine withdrawal questionnaire at baseline and follow-up</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety including adverse events, ECGs, vital signs, routine laboratory tests throughout the study</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">135</enrollment>
  <condition>Sleep Initiation and Maintenance Disorders</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>EVT 201</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of primary insomnia according to DSM-IV

          -  Over the last three months for at least 5 nights per week, must have a normal bedtime
             of between 9 pm and 1 am and a time in bed of at least 7 hours

          -  A history of sleepiness, tiredness or unintentional napping during the daytime
             attributed to to poor sleep at night

          -  Able to attend the Sleep Center for five nights (two consecutive nights on two
             occasions and one night on one occasion)over a five week period

          -  Willing and able to complete a sleep diary and questionnaires

        Exclusion Criteria:

          -  Clinically significant or unstable medical condition that may interfere with sleep

          -  Major psychiatric disorders (other than insomnia) such as depression, schizophrenia,
             bipolar disorder

          -  History of myocardial infarction, cardiac failure or clinically significant
             dysrhythmias in the previous 2 years or clinically significant ECG abnormalities at
             screening

          -  History of substance abuse

          -  Disorders that interfere with drug pharmacokinetics

          -  History of cancer, except basal cell carcinoma

          -  Use of hypnotics, anxiolytics, antidepressants, anticonvulsants, over-the-counter
             sleep aids, histamine-1 receptor antagonists (except for loratadine and fexofenadine),
             beta-adrenergic blockers (except for atenolol), respiratory stimulants and
             decongestants, systemic steroids, narcotic analgesics, any other compound which might
             impact sleep-wake function, or medication used for the treatment of Parkinson's
             disease such as dopamine agonists and L-dopa (e.g., Sinemet, Madopar or Requip)

          -  Use of hypnotics within the 2 weeks preceding the Screening Period or within five
             half-lives of the medication, whichever is longer

          -  Consuming ≥ 350 mg per day of xanthine-containing food or beverages

          -  Smoking ≥ 10 cigarettes per day and/or unable to refrain from smoking without distress
             or discomfort for the duration of visits to the sleep laboratory (i.e.≥ 20 hours)

          -  Body mass index &gt; 34 kg/m2;

          -  Performing night work or rotating shift work during the past month

          -  Traveling across &gt; 3 time zones in the past 2 weeks

          -  Participation in another trial of an investigational product or device within the
             previous 30 days

          -  Known allergy or sensitivity to benzodiazepines
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James K Walsh, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St Luke's Hospital, Sleep Medicine and Research Center, Chesterfield, MI</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>PsyPharma Clinical Research Inc.</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85050</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PsyPharma Clinical Research, Inc.</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85712</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pacific Sleep Medicine Services Inc</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pacific Sleep Medicine Services</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Miami Research Associates</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>OmniTrials, 11181 Health Park Blvd, Suite 3040</name>
      <address>
        <city>Naples</city>
        <state>Florida</state>
        <zip>34110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Broward Research Group</name>
      <address>
        <city>Pembroke Pines</city>
        <state>Florida</state>
        <zip>33026</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Research Group of St Petersburg Inc., 2525 Pasadena Ave So, Suite S</name>
      <address>
        <city>St Petersburg</city>
        <state>Florida</state>
        <zip>33707</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Sleep Disorders Center of Georgia, Peachtree Dunwoody Medical Center, 5505 Peachtree Dunwoody Road, Suite 548</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sleep Disorders Center of Georgia - Gainesville</name>
      <address>
        <city>Gainesville</city>
        <state>Georgia</state>
        <zip>30501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vince and Assocaites Clinical Research</name>
      <address>
        <city>Overland Park</city>
        <state>Kansas</state>
        <zip>66212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Community Research</name>
      <address>
        <city>Crestview Hills</city>
        <state>Kentucky</state>
        <zip>41017</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center for Sleep Medicine, 101 Courtney Circle</name>
      <address>
        <city>Hattiesburg</city>
        <state>Mississippi</state>
        <zip>39402</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sleep Medicine and Research Center, 232 S. Woods Mill Road</name>
      <address>
        <city>Chesterfield (St Louis)</city>
        <state>Missouri</state>
        <zip>63017</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinilabs, Inc., 423 West 55th Street, 4th Floor</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10019</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke Insomnia and Sleep Research, Duke South Hospital, Room 54242, Trent Drive</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Community Research</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45227</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tri-State Sleep Disorders Center, 1275 East Kemper Road</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45246</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bradley Hospital Sleep Research Laboratory, 300 Duncan Drive</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02906</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sleep Disorders Center, 1333 Taylor Street, Suite 5A</name>
      <address>
        <city>Columbia</city>
        <state>South Carolina</state>
        <zip>29201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sleep Medicine Associates p.a., 5477 Glen Lakes Drive, Suite 125</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75231</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baylor College of Medicine, VAMC-Sleep Laboratory, 2002 Holcombe Boulevard , Room 6C-344</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 17, 2006</study_first_submitted>
  <study_first_submitted_qc>November 17, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2006</study_first_posted>
  <last_update_submitted>January 2, 2008</last_update_submitted>
  <last_update_submitted_qc>January 2, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 7, 2008</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

